The scientific and clinical basis for the treatment of Parkinson disease (2009)

疾病 医学 帕金森病 重症监护医学 痴呆 临床试验 人口 左旋多巴 生活质量(医疗保健) 病理 护理部 环境卫生
作者
C. Warren Olanow,Matthew B. Stern,Kapil D. Sethi
出处
期刊:Neurology [Lippincott Williams & Wilkins]
卷期号:72 (21_supplement_4): S1-136 被引量:874
标识
DOI:10.1212/wnl.0b013e3181a1d44c
摘要

Parkinson disease (PD) is an age-related neurodegenerative disorder that affects as many as 1-2% of persons aged 60 years and older. With the aging of the population, the frequency of PD is expected to increase dramatically in the coming decades. Current therapy is largely based on a dopamine replacement strategy, primarily using the dopamine precursor levodopa. However, chronic treatment is associated with the development of motor complications, and the disease is inexorably progressive. Further, advancing disease is associated with the emergence of features such as freezing, falling, and dementia which are not adequately controlled with dopaminergic therapies. Indeed, it is now appreciated that these nondopaminergic features are common and the major source of disability for patients with advanced disease. Many different therapeutic agents and treatment strategies have been evaluated over the past several years to try and address these unmet medical needs, and many promising approaches are currently being tested in the laboratory and in the clinic. As a result, there are now many new therapies and strategic approaches available for the treatment of the different stages of PD, with which the treating physician must be familiar in order to provide patients with optimal care. This monograph provides an overview of the management of PD patients, with an emphasis on pathophysiology, and the results of recent clinical trials. It is intended to provide physicians with an understanding of the different treatment options that are available for managing the different stages of the disease and the scientific rationale of the different approaches.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
可爱的函函的应助被细心沂采纳,获得10
刚刚
脑洞疼的应助被繁荣的萝莉采纳,获得10
刚刚
刚刚
虾米米0918完成签到 ,获得积分10
1秒前
2秒前
铠甲勇士完成签到,获得积分10
2秒前
可爱的函函的应助被林慧宁采纳,获得10
2秒前
锂离子发布了新的文献求助10
2秒前
3秒前
天天快乐的应助被WGZ1980049314采纳,获得10
3秒前
4秒前
4秒前
5秒前
obcx发布了新的文献求助10
6秒前
7秒前
yuyu发布了新的文献求助10
7秒前
隐形曼青的应助被坚强孤容采纳,获得10
7秒前
zk1438328200完成签到,获得积分10
9秒前
专注的荣轩完成签到,获得积分10
9秒前
luo运俊发布了新的文献求助10
9秒前
9秒前
orixero的应助被刺五加采纳,获得10
9秒前
LpmxRk发布了新的文献求助10
9秒前
科目三的应助被细心沂采纳,获得10
9秒前
李健的小迷弟的应助被CJX采纳,获得10
10秒前
科研顺利发布了新的文献求助10
10秒前
整齐芷文完成签到,获得积分10
11秒前
暴躁的紫青完成签到,获得积分20
12秒前
逐徒发布了新的文献求助10
12秒前
111完成签到,获得积分10
12秒前
钟钟完成签到 ,获得积分10
13秒前
14秒前
科研通AI6.3的应助被孤星采纳,获得10
15秒前
luo运俊完成签到,获得积分10
15秒前
科研通AI6.2的应助被yuyu采纳,获得10
15秒前
15秒前
奈何完成签到 ,获得积分10
16秒前
不吃辣完成签到,获得积分10
17秒前
18秒前
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186806
求助须知:如何正确求助?哪些是违规求助? 9575125
关于积分的说明 21839712
捐赠科研通 7784453
什么是DOI,文献DOI怎么找? 3434839
关于科研通互助平台的介绍 2559245
邀请新用户注册赠送积分活动 2481712